Threshold Pharmaceuticals (THLD) Reports In-Line Q3 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts THLD Hot Sheet
Price: $0.54 --0%
Financial Fact:
Research and development: 3.52M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 3.52M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Threshold Pharmaceuticals (NASDAQ: THLD) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.29 million.
For earnings history and earnings-related data on Threshold Pharmaceuticals (THLD) click here.
For earnings history and earnings-related data on Threshold Pharmaceuticals (THLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
